abstract |
The present invention relates to the field of medicine. It relates more particularly to the use of compounds for preventing and / or treating, in a subject, myopathy, typically muscular dystrophy or cardiomyopathy, or muscle trauma. The invention also relates to the compositions, in particular pharmaceutical compositions comprising such compounds, as well as their uses for preventing and / or treating muscular myopathy or trauma. The compounds and compositions according to the invention can typically be advantageously used to prevent and / or treat muscular dystrophy, cardiomyopathy or muscular trauma, preferably Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (DMB) and or a symptom or abnormality characteristic of DMD or DMB. |